Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
migraine
2
×
national blog main
new york blog main
abbvie
acute migrane
allergan
amgen
bain capital
bausch health
biohaven
breast cancer
cgpr
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
eli lilly
europe blog main
fda
generic drug
glaxosmithkline
impel neuropharma
medical device
merck
multiple myeloma
national
national organization for rare disorders
national top stories
new york
new york top stories
nirogacestat
orbimed
ra capital
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san francisco blog main
san francisco top stories
What
migraine
2
×
activity
adults
allergan
approved
biotech
class
companies
days
dog
drug
fda
firm
hasn’t
ipo
ipos
leading
line
medicines
monday
new
nod
pfizer
pill
place
prep
satsuma
securing
slowed
spinout
springworks
stopped
summer
treat
treatment
ubrelvy
ubrogepant
wins
Language
unset
2
×
Current search:
migraine
×
unset
×
migraine
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
